J1813 – Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units

Long description

Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units

Short description

Lyumjev for insulin pump use

Pricing indicator

51 Drugs

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

D1G Drugs Administered through DME

ASC

Approved for ambulatory surgical centers

Added

July 1, 2023

Last change

January 1, 2024 – No change

Nearby J codes

• J1805 – Injection, esmolol hydrochloride, 10 mg
• J1806 – Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mg
• J1807 – Injection, ethacrynate sodium, 1 mg
• J1808 – Injection, folic acid, 0.1 mg
• J1809 – Injection, fosdenopterin, 0.1 mg
• J1810 – Injection, droperidol and fentanyl citrate, up to 2 ml ampule
• J1811 – Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units
• J1812 – Insulin (fiasp), per 5 units
• J1814 – Insulin (lyumjev), per 5 units
• J1815 – Injection, insulin, per 5 units
• J1817 – Insulin for administration through dme (i.e., insulin pump) per 50 units
• J1818 – Injection, pegzilarginase-nbln, 0.05 mg
• J1823 – Injection, inebilizumab-cdon, 1 mg
• J1826 – Injection, interferon beta-1a, 30 mcg
• J1830 – Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
• J1833 – Injection, isavuconazonium, 1 mg